RespireRx Pharmaceuticals Inc. (RSPI)
OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
At close: 03:46PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.72M |
| Enterprise value | 5.31M |
| Trailing P/E | 0.02 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.66 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.17 |
| 52-week change 3 | 143.33% |
| S&P500 52-week change 3 | 23.20% |
| 52-week high 3 | 0.0069 |
| 52-week low 3 | 0.0006 |
| 50-day moving average 3 | 0.0017 |
| 200-day moving average 3 | 0.0013 |
Share statistics
| Avg vol (3-month) 3 | 23.34M |
| Avg vol (10-day) 3 | 21.28M |
| Shares outstanding 5 | 471.74M |
| Implied shares outstanding 6 | 471.74M |
| Float 8 | 354.41M |
| % held by insiders 1 | 6.63% |
| % held by institutions 1 | 0.00% |
| Shares short (30 Nov 2009) 4 | 126 |
| Short ratio (30 Nov 2009) 4 | 1.47 |
| Short % of float (30 Nov 2009) 4 | 0.61% |
| Short % of shares outstanding (30 Nov 2009) 4 | 0.60% |
| Shares short (prior month 30 Oct 2009) 4 | 245 |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 06 Jan 2021 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 06 Jan 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -1,104.95% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -2.17M |
| Diluted EPS (ttm) | -0.0200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.36k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 2.78M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.01 |
| Book value per share (mrq) | -0.04 |
Cash flow statement
| Operating cash flow (ttm) | -247.57k |
| Levered free cash flow (ttm) | -661.03k |
© 2024 Yahoo. All rights reserved.